• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 11
  • 7
  • 4
  • 3
  • 2
  • 1
  • Tagged with
  • 33
  • 33
  • 21
  • 20
  • 19
  • 8
  • 7
  • 7
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Targeting gene therapy to neuroinfalmmatory lesions in experimental autoimmune encephalomyelitis / Gezielte Gentherapieauf Rückenmarkentzündungsläsionen in experimenteller autoimmuner Enzephalomyelitis

Rochford, Christian 21 January 2005 (has links)
No description available.
22

Vom Modell zur Therapie

Hildebrandt, Martin 06 February 2003 (has links)
Mit der vorliegenden Habilitationsschrift habe ich den Versuch unternommen, die beiden Themenkomplexe meiner bisherigen wissenschaftlichen Tätigkeit als Beispiele für die Rolle von Modellen in der klinischen Forschung zu verwenden. Den Ansto§ dazu gaben Diskrepanzen, die mir in der Auseinandersetzung mit eigenen Ergebnissen und Beobachtungen im Umfeld dieser Themenkomplexe aufgefallen sind: der Rolle kontaminierender Tumorzellen in der Hochdosistherapie maligner Tumoren einerseits und dem Enzym Dipeptidylpeptidase IV (DPP IV) andererseits. Die beobachteten Diskrepanzen sind Ausdruck konkurrierender pathophysiologischer oder therapeutischer Modelle, und die Präferenz eines bestimmten Modells scheint nicht rein rational erklärbar. Welche Faktoren tragen jedoch zur Entscheidung für oder gegen ein bestimmtes Modell bei? Ich möchte den Umgang mit wissenschaftlichen Modellen anhand der genannten Themenkomplexe aus meiner Sicht erörtern. Anschlie§end soll ein Entwurf skizziert werden, in dem die der Entscheidung für oder gegen ein therapeutisches Modell zugrundeliegende Motivationslage besser verständlich wird und die Intentionalität klinischer Forschung auf den Patienten hin berücksichtigt. / In the thesis presented here, I have taken the challenge to use the topics of my scientific work to discuss the role that models appear to exert in clinical science. This decision arose from discrepancies that became evident in the comparative assessment of my own studies in relation with the surrounding scientific context: the role of tumor cells contaminating peripheral blood or progenitor cell harvests as part of a high-dose chemotherapy regimen on the one hand, and the enzyme dipeptidyl peptidase IV (DPP IV) on the other. The observed discrepancies appear to result from competing pathophysiological or therapeutic models, and the preference or rejection of one model apparently cannot be explained solely by rational factors. I will discuss the application of models in the context of the topics which my scientific work has been focusing on, and I will develop a draft proposal which will render the individual motivational status underlying the decision in favor of or against a distinct model easier to understand, with attention to the intentionality of clinical research towards the patient.
23

Avaliação da viabilidade financeira do banco do sangue de cordão umbilical do Hemocentro de Ribeirão Preto / Evaluation of financial viability of the umbilical cord blood bank of the Hemocentro de Ribeirão Preto

Zanelli, Ana Paula Rocha Diniz 02 March 2017 (has links)
Introdução. As células progenitoras hematopoéticas (CPH) têm sido utilizadas no tratamento de algumas doenças malignas hematológicas e de desordens hematopoéticas. Dentre estas células estão as CPHs provenientes de cordão umbilical e placentário (SCUP). Para coleta e armazenamento destas células foram criados os Bancos de Sangue de Cordão Umbilical e Placentário (BSCUP). No Brasil existe a rede BrasilCord e o BSCUP do Hemocentro de Ribeirão Preto é um dos que compõem esta rede. Objetivo. Avaliar a viabilidade financeira de um banco de sangue de cordão umbilical e placentário público comparando os custos de seus procedimentos com os valores ressarcidos definidos pela tabela SUS. Metodologia: Este estudo utilizou a metodologia de Custeio Baseado em Atividades (Activity-Based Costing - ABC), que procura reduzir as distorções provocadas pelo rateio arbitrário dos custos indiretos utilizando direcionadores de custos. Foram avaliados os custos diretos e indiretos da coleta, transporte, processamento, testagem e criopreservação de CPH proveniente de SCUP no primeiro semestre de 2015. Para os custos indiretos foram definidos os direcionadores de custo. Resultados Os resultados mostram que o BSCUP do Hemocentro de Ribeirão Preto foi deficitário no primeiro semestre de 2015. O déficit apurado por unidade foi de R$1.155,69 para o processamento semiautomatizado e R$1.703,78 para o processamento automatizado. O déficit total no período foi de R$ 100.376,50 quando 50 unidades foram processadas utilizando o método semiautomatizado e 25 pelo método automatizado. Conclusão. O valor ressarcido pelo SUS não cobre os gastos do BSCUP do Hemocentro de Ribeirão Preto. Isso pode ser atribuído a várias causas como: sistemática de pagamento pelo SUS apenas pelo produto criopreservado, elevados índices de rejeição das doadoras na maternidade e de descarte das unidades coletadas, embora este último seja menor que o descrito na literatura, e o custo do armazenamento em longo prazo. Os custos do BSCUP são menores que os descritos na literatura e poderiam ser reduzidos com melhorias de processos de gestão e aumento do número de unidades criopreservadas, bem como, por meio de descentralização de coletas para processamento centralizado. / Introduction. Hematopoietic progenitor cells (HPC) are being used in some hematologic malignancies and hematopoietic disorders treatment. Among these cells are the HPCs from umbilical blood cord (UCB). Umbilical cord blood banks were created to collect and store these cells. In Brazil there is a net called Brasilcord and the umbilical cord blood bank (UCBB)of the Hemocentro de Ribeirão Preto belongs to this net. Objective. To evaluate the financial viability of a public umbilical cord blood bank and compare the costs from its procedure with the values reimbursed defined by the SUS table. Methodology.This study used the ActivityBased Costing, which tries to reduce distortions caused by arbitrary apportionment of indirect costs using cost drivers. Direct and indirect costs of collection, transport, processing, testing and cryopreservation of HPCs from umbilical cord blood were evaluated. Cost drivers were defined for indirect costs. Results. The results showed that there was a deficit in the UCBB of the Hemocentro de Ribeirão Preto in the first semester of 2015. The deficit was R$1.155,69 when the unit was processed by the semi-automated method and R$1.703,78 when it was processed by an automated method. The total deficit in the period was R$100.376,50 as 50 units were processed by a semi-automated method and 25 by an automated method. Conclusion. The amount reimbursed by SUS does not cover the UCBB of Hemocentro de Ribeirão Preto expenses. This can be attributed to several causes such as: systematic of reimbursement used by SUS that only cryopreserved units are payed, high percentage of deferral in the maternity and of discard of collected units, although this latter is smaller than that described in the literature and the cost of storage of the units for long periods. The costs of UCBB are lower than that described in the literature and could be reduced with improvements in managing process and increase the number of cryopreserved units as well as decentralization of collections for centralizes processing.
24

Διερεύνηση του ρόλου της Geminin στην ανάπτυξη και διαφοροποίηση αρχέγονων/προγονικών κυττάρων του αιμοποιητικού συστήματος σε γενετικά τροποποιημένους μύες

Καραμήτρος, Δημήτριος 30 May 2012 (has links)
Κατά την ανάπτυξη ενός οργανισμού η απόκτηση εξειδικευμένων κυτταρικών λειτουργιών είναι μια προοδευτική διαδικασία η οποία περιλαμβάνει την ασύμμετρη διαίρεση των βλαστικών κυττάρων για την παραγωγή προγονικών κυττάρων τα οποία σταδιακώς εξέρχονται από τον κυτταρικό κύκλο και διαφοροποιούνται μέσω της εγκαθίδρυσης του κατάλληλου μεταγραφικού προγράμματος. Προκειμένου να κατανοήσουμε τη ρύθμιση αυτών των γεγονότων μελετήσαμε την Geminin, ένα κεντρικό ρυθμιστή του κυτταρικού κύκλου, στο ανοσοποιητικό σύστημα. Δημιουργήσαμε ζωικά μοντέλα στα οποία απενεργοποιήσαμε το γονίδιο της Geminin στα λεμφοκύτταρα. Τα αποτελέσματα μας έδειξαν ότι η απενεργοποίηση της Geminin στα λεμφοκύτταρα δεν επηρεάζει σημαντικά τη διαφοροποίηση των προγονικών Τ κυττάρων στο θύμο. Απουσία της Geminin τα προγονικά θυμοκύτταρα δεσμεύονται προς διαφοροποίηση στην Τ κυτταρική σειρά και παράγουν διαφοροποιημένα θυμοκύτταρα. Παρατηρήθηκαν μικρές μειώσεις στον αριθμό των DN1, DN4 και DP κυττάρων. Σε αντίθεση τα αθώα (naïve), ρυθμιστικά (regulatory) και Τ κύτταρα μνήμης (memory T cells), παρουσίασαν σημαντικές μειώσεις απουσία της Geminin. Επιπλέον βρήκαμε ότι ο πολλαπλασιασμός των περιφερικών Τ κυττάρων ύστερα από την ενεργοποίηση τους μέσω του TCR υποδοχέα παρουσίασε σημαντικές ανωμαλίες ενώ παρατηρήθηκαν και σημαντικές διαταραχές της προόδου του κυτταρικού κύκλου απουσία της Geminin. Οι μεταβολές που παρατηρήθηκαν στην έκφραση του Cdt1 και σε κυκλίνες των ενεργοποιημένων περιφερικών Τ κυττάρων μπορεί να εμπλέκονται στο μηχανισμό που εξηγεί τις διαταραχές των περιφερικών Τ κυττάρων απουσία της Geminin. Επίσης Τ κύτταρα από τα οποία είχε απενεργοποιηθεί η Geminin δεν είναι ικανά να αποικίσουν τα λεμφοειδή όργανα μυών από τους οποίους απουσιάζουν τα λεμφοκύτταρα, αποτέλεσμα το οποίο δείχνει διαταραχές του ομοιοστατικού πολλαπλασιασμού αυτών των κυττάρων. Συμπερασματικά η Geminin είναι απαραίτητη για την αυστηρή ρύθμιση των επαναλαμβανόμενων κυτταρικών διαιρέσεων των περιφερικών Τ κυττάρων αλλά δεν επηρεάζει σημαντικά την διαφοροποίηση των προγονικών Τ κυττάρων. Επιπλέον τα αποτελέσματα αυτά προτείνουν ότι υπάρχουν εγγενείς διαφορές στην ρύθμιση του κυτταρικού κύκλου μεταξύ θυμοκυττάρων και περιφερικών Τ κυττάρων. / During development, acquisition of specialized function is a progressive, gradual process that involves the asymmetric divisions of stem cells to generate progeny that will exit the cell cycle and terminally differentiate through the establishment of an appropriate transcriptional program. In order to understand this process we studied Geminin, a key cell cycle regulator, that has been shown to affect cellular decisions of differentiation. Towards this direction we focused on the immune system and investigated the role of Geminin in self-renewal and differentiation of stem and progenitor cells. In order to gain insight into the in vivo role of Geminin in progenitor cell division and differentiation, we have deleted Geminin in cells of the lymphoid lineage. The inactivation of Geminin in the lymphoid lineage does not alter progenitor T cell differentiation in the thymus. In the absence of Geminin progenitor T cells commit, differentiate and generate differentiated thymocytes. Minor reduction in the number of DN1, DN4 and DP progenitor T cells were observed. In contrast naïve, regulatory and memory peripheral T cells show a significant reduction in the absence of Geminin. Moreover, proliferation of Geminin deficient peripheral T cells upon TCR activation is severely compromised, accompanied by cell cycle progression defects. The deregulated protein levels of Cdt1 and cyclins in activated peripheral T cells lacking Geminin, may be involved in the mechanism responsible for the observed phenotype of Geminin deficient peripheral T cells. More importantly Geminin deficient T cells fail to repopulate lymphopenic hosts suggesting defects in homeostatic proliferation. In conclusion Geminin is essential to regulate the repeated divisions of peripheral T cells but does not significantly affect progenitor T cell differentiation. In addition our results suggest that there are intrinsic differences in cell cycle regulation of thymocytes and peripheral T cells.
25

Avaliação da viabilidade financeira do banco do sangue de cordão umbilical do Hemocentro de Ribeirão Preto / Evaluation of financial viability of the umbilical cord blood bank of the Hemocentro de Ribeirão Preto

Ana Paula Rocha Diniz Zanelli 02 March 2017 (has links)
Introdução. As células progenitoras hematopoéticas (CPH) têm sido utilizadas no tratamento de algumas doenças malignas hematológicas e de desordens hematopoéticas. Dentre estas células estão as CPHs provenientes de cordão umbilical e placentário (SCUP). Para coleta e armazenamento destas células foram criados os Bancos de Sangue de Cordão Umbilical e Placentário (BSCUP). No Brasil existe a rede BrasilCord e o BSCUP do Hemocentro de Ribeirão Preto é um dos que compõem esta rede. Objetivo. Avaliar a viabilidade financeira de um banco de sangue de cordão umbilical e placentário público comparando os custos de seus procedimentos com os valores ressarcidos definidos pela tabela SUS. Metodologia: Este estudo utilizou a metodologia de Custeio Baseado em Atividades (Activity-Based Costing - ABC), que procura reduzir as distorções provocadas pelo rateio arbitrário dos custos indiretos utilizando direcionadores de custos. Foram avaliados os custos diretos e indiretos da coleta, transporte, processamento, testagem e criopreservação de CPH proveniente de SCUP no primeiro semestre de 2015. Para os custos indiretos foram definidos os direcionadores de custo. Resultados Os resultados mostram que o BSCUP do Hemocentro de Ribeirão Preto foi deficitário no primeiro semestre de 2015. O déficit apurado por unidade foi de R$1.155,69 para o processamento semiautomatizado e R$1.703,78 para o processamento automatizado. O déficit total no período foi de R$ 100.376,50 quando 50 unidades foram processadas utilizando o método semiautomatizado e 25 pelo método automatizado. Conclusão. O valor ressarcido pelo SUS não cobre os gastos do BSCUP do Hemocentro de Ribeirão Preto. Isso pode ser atribuído a várias causas como: sistemática de pagamento pelo SUS apenas pelo produto criopreservado, elevados índices de rejeição das doadoras na maternidade e de descarte das unidades coletadas, embora este último seja menor que o descrito na literatura, e o custo do armazenamento em longo prazo. Os custos do BSCUP são menores que os descritos na literatura e poderiam ser reduzidos com melhorias de processos de gestão e aumento do número de unidades criopreservadas, bem como, por meio de descentralização de coletas para processamento centralizado. / Introduction. Hematopoietic progenitor cells (HPC) are being used in some hematologic malignancies and hematopoietic disorders treatment. Among these cells are the HPCs from umbilical blood cord (UCB). Umbilical cord blood banks were created to collect and store these cells. In Brazil there is a net called Brasilcord and the umbilical cord blood bank (UCBB)of the Hemocentro de Ribeirão Preto belongs to this net. Objective. To evaluate the financial viability of a public umbilical cord blood bank and compare the costs from its procedure with the values reimbursed defined by the SUS table. Methodology.This study used the ActivityBased Costing, which tries to reduce distortions caused by arbitrary apportionment of indirect costs using cost drivers. Direct and indirect costs of collection, transport, processing, testing and cryopreservation of HPCs from umbilical cord blood were evaluated. Cost drivers were defined for indirect costs. Results. The results showed that there was a deficit in the UCBB of the Hemocentro de Ribeirão Preto in the first semester of 2015. The deficit was R$1.155,69 when the unit was processed by the semi-automated method and R$1.703,78 when it was processed by an automated method. The total deficit in the period was R$100.376,50 as 50 units were processed by a semi-automated method and 25 by an automated method. Conclusion. The amount reimbursed by SUS does not cover the UCBB of Hemocentro de Ribeirão Preto expenses. This can be attributed to several causes such as: systematic of reimbursement used by SUS that only cryopreserved units are payed, high percentage of deferral in the maternity and of discard of collected units, although this latter is smaller than that described in the literature and the cost of storage of the units for long periods. The costs of UCBB are lower than that described in the literature and could be reduced with improvements in managing process and increase the number of cryopreserved units as well as decentralization of collections for centralizes processing.
26

Qualificação das unidades de SCUP criopreservadas no banco de sangue de cordão umbilical e placentário da Fundação HEMOPE no período de dezembro de 2014 a junho de 2017 / Qualification of cryopreserved SCUP units in the umbilical cord and placental blood bank of the HEMOPE Foundation from December 2014 to June 2017

Costa, Ana Maria do Nascimento 07 November 2018 (has links)
Qualificar as primeiras unidades de Sangue de Cordão Umbilical e Placentá- rio (SCUP) criopreservadas no Banco de Sangue Umbilical e placentário da Fundação de Hematologia e Hemoterapia de Pernambuco (BSCUP/HEMOPE), no período de dezembro de 2014 a junho de 2017. Justificativa: O sangue do cordão é rico em células progenitoras hematopoéticas (CPH), utilizado para transplante e tratamento de patologias benignas e malignas. Avaliar as primeiras unidades coletadas no BSCUP/ HEMOPE será de grande valia para sua caracterização, planejamento de ações de melhoria do processo, contribuindo para o aumento da eficácia dos transplantes. Métodos: Foram triadas gestantes sem histórico de diagnóstico para doenças transmissíveis pelo sangue, com gestação terminada em recém-nascido (RN) vivo; caracterizadas através das variáveis sociodemográficas: idade, idade gestacional, antecedentes obstétricos e cor da pele dos RN foram caracterizados pelas variáveis explicativas: Gênero e Peso; as amostras das mães foram coletadas no dia do parto ou em até 48h após. O tempo entre o término da coleta e o início da criopreservação da unidade das CPH não excedeu 48 horas. As unidades de SCUP foram avaliadas quanto ao volume, total de células nucleadas (TCN), quantificação de células CD 34+, contagem de eritroblastos viabilidade celular e contaminação microbiológica. Neste estudo foi avaliada a variável \"unidades adequadas ao uso em relação ao peso do receptor, tomando com o base o TCN e o peso de um provável receptor, assim categorizados: unidades <12,5 x10e8 para peso 12,5 para peso >50kg; Resultados: Volume Inicial (ml):(min.50,0; max.166,80); Volume final(mL): (min.19,07;max.21,75); TCN pré (x108): (min.6,0;max.27,80);TCN pós(x108): (min.5,0; max.22,6); Recuperação Celular (%): (min.0,67; max.39,50); CD34+(x106):(min.0,67;max.39,50);Viabilidade(%): (min.71,35max.100); Conclusão: Das 113 unidades armazenadas, 89 (78,76%) atendem a receptores < 50kg (crianças) e 24 (21,24%) atendem a receptores >50k (adultos). O inventário apresentou resultados em conformidades com o especificado na legislação vigente, portanto, qualificadas para atender à demanda transfusional de transplantes de CPH. / To qualify the first units of cryopreserved Umbilical Cord and Placental Blood (SCUP) in the Umbilical and Placental Blood Bank of the Hematology and Hemotherapy Foundation of the State of Pernambuco (BSCUP / HEMOPE), from December 2014 to June 2017 Rationale: Cord blood is rich in hematopoietic progenitor cells (HPC), used for transplantation and treatment of benign and malignant pathologies. Evaluating the first units collected in the BSCUP / HEMOPE will be of great value for its characterization, planning of actions to improve the process, contributing to increase the efficiency of transplants. Methods: Pregnant women with no history of diagnosis for blood-borne diseases were screened, with gestation terminated in live newborn (NB); characterized by the sociodemographic variables: age, gestational age, obstetric history and skin color, NB were characterized by the explanatory variables: Gender and Weight; the samples of the mothers were collected on the day of delivery or within 48 hours after delivery. The time between the end of the collection and the beginning of the cryopreservation of the MHC unit did not exceed 48 hours. SCUP units were evaluated for volume, total nucleated cells (TNC), CD34 + cell count, cell viability erythroblast counts, and microbiological contamination. In this study, the variable \"units suitable for use in relation to the weight of the receptor\" was evaluated, taking as base the TNC and the weight of a probable receiver, as follows: units <12.5 x10e8 for weight 12 , 5 for weight> 50 kg; Results: Initial volume (ml): (min.50.0, max.166.80); Final volume (mL): (min.19.07, max.21.75); TCN pre (x108): (min.6,0; max.27,80); TCN post (x108): (min.5,0; max.22,6); Cellular Recovery (%): (min.0.67, max.39,50); CD34 + (x106): (min.0.67, max.39.50); Viability (%): (min.71,35max.100); : Of the 113 stored units, 89 (78.76%) attend to receptors <50kg (children) and 24 (21.24%) attend receptors> 50k (adults). Conclusion: The inventory presented results in compliance with that specified in current legislation, therefore, qualified to meet the transfusional demand for HPC transplants.
27

Expansão ex vivo das células-tronco hematopoiéticas do sangue do cordão umbilical: análise comparativa da proliferação celular em cocultura de células-troco mesenquimais provenientes do endotélio vascular do cordão umbilical e do tecido adiposo / Cord blood hematopoietic stem cells ex vivo expansion: comparative analysis of cell proliferation promoted by adipose tissue and umbilical cord endothelium mesenchymal stem cells in coculture system

Forte, Andresa 10 December 2014 (has links)
INTRODUÇÃO: As células-tronco hematopoiéticas (CTH) do sangue do cordão umbilical (SCU) têm sido utilizadas com sucesso para o tratamento de doenças malignas e não malignas. No entanto, algumas unidades de SCU podem apresentar baixa quantidade de células nucleadas totais (CNT). Algumas abordagens têm sido sugeridas para evitar problemas em relação à baixa concentração de CTH no transplante, como a administração de duas unidades de SCU para o paciente e a expansão ex vivo de CTH. OBJETIVO: Avaliar as taxas de proliferação celular na expansão ex vivo do SCU em sistema de cocultura com células-tronco mesenquimais (CTM) obtidos a partir de diferentes fontes com alta e baixa confluência e adicionando-se ou não coquetel de citocinas no meio de cultura. MÉTODOS: Este estudo foi aprovado pelo Comitê de Ética de Pesquisa (CAPPesq) do Hospital das Clínicas da Faculdade de Medicina da USP. A coleta do SCU (n =10) foi realizada após o nascimento do bebê e expulsão da placenta. O processamento foi realizado utilizando o método de redução de volume, o qual consiste em depleção de eritrócitos. As amostras de CTM provenientes do endotélio vascular do cordão umbilical foram obtidas de doadores diferentes (n=3) e o tecido adiposo (n=3) do inventário do LIM-31. A expansão das CNT e das células com expressão de marcadores CD133+/CD34+ foram observados depois de sete dias de cultura. Além disso, o ensaio para análise de unidades de formadoras de colônias (UFC) foi realizado em todas as amostras antes e depois da expansão do SCU. Para a expansão em sistema de cocultura foi separado dois grupos para ambas as fontes de CTM (Grupo I - cocultura com adição de coquetel de citocinas vs. Grupo II - cocultura sem citocinas). RESULTADOS: Após sete dias, no grupo I com cocultura confluente, a taxa de proliferação de CNT foi duas vezes maior ao comparar com cocultura subconfluente (35 vs. 16 vezes). No mesmo grupo também foi possível evidenciar elevada taxa de proliferação de células CD133+/CD34+. O índice de proliferação das UFC no grupo I aumentou até oito vezes. A cocultura subconfluente tanto do endotélio vascular do cordão umbilical como do tecido adiposo apresentou menor rendimento em comparação as CTM confluentes. A expansão das células na presença de citocinas apresentou maior proliferação celular ao comparar às coculturas sem adição de citocinas. CONCLUSÃO: Este estudo mostrou que para alto rendimento de células do SCU, o sistema de cocultura requer adição de coquetel de citocinas e CTM confluente independentemente da fonte utilizada / INTRODUCTION: Umbilical cord blood (UCB) hematopoietic stem cells have been successfully used for the treatment of both malignant and non-malignant diseases. Nevertheless, some UCB units could have low total nucleated cells (TNC) dose. Several approaches have been suggested to avoid inadequacy problems of hematopoietic stem cells (HSC) number for transplantation, such as administration of two UCB units to the patient and HSC ex vivo expansion. OBJECTIVE: Evaluate UCB ex vivo expansion proliferative rates in a high and low mesenchymal stem cells (MSC) confluence feeder layer obtained from different MSC sources and by adding or not cytokines cocktail into the medium. METHODS: This study was approved by the Research Ethic Committee (CAPPESQ) of Hospital das Clínicas da Faculdade de Medicina da USP. The collection of UCB (n=10) was made after delivery of the infant and the expulsion of placenta. Processing was performed using volume reduction method which consists in red blood depletion. MSC samples from umbilical cord endothelium were obtained from three different donors and adipose tissue (n=3) obtained from LIM31\'s pattern inventory. The total nucleated cell (TNC), expression of hematopoietic surface markers such as CD133+/CD34+ were observed after seven days of culture. Beyond that, colony forming unit assay (CFU) was performed before and after UCB expansion. The expansion by coculture method was observed in two groups (Group I - coculture with cytokines cocktail added vs. Group II- coculture without cytokines cocktail) for both MSCs sources. RESULTS: After seven days, analysis of confluent coculture showed that TNC proliferation rate ware almost 2 times higher than in subconfluent coculture (35 vs. 16-fold) in Group I and also revealed higher proliferative rate in CD133+/CD34+ cells considering. CFU showed similar increase after seven days of culture in comparison of day 0 (up to 8-fold). Subconfluent coculture for both umbilical cord endothelium and adipose tissue showed lower yield compared with those with high MSC confluence. The expansion in the presence of cytokines showed higher cell proliferation compared to the cocultures without addition of cytokines. CONCLUSION: This study showed that coculture system may require the addition of cytokines cocktail in the media and confluent MSC regardless of source for high yield of UCB cells
28

Cell therapy for cardiac tissue repair by circulting stem cells/Thérapie cellulaire de réparation tissulaire cardiaque par cellules souches circulantes

Delgaudine, Marie 13 December 2010 (has links)
Le traitement de pathologies cardiaques ischémiques est limité par labsence de capacité régénérative du myocarde. Plusieurs études ont suggéré le potentiel de régénération du myocarde des cellules souches hématopoïétiques (CSH), mésenchymateuses (CSM) et des cellules progénitrices endothéliales (CPE). Une des stratégies envisageables en thérapie cellulaire est la mobilisation des cellules souches adultes de moelle osseuse (MO) dans le sang périphérique (SP) afin quelles puissent participer aux phénomènes de réparation tissulaire cardiaque. Le G-CSF est une cytokine puissante dont il a été démontré quelle pouvait améliorer la fonction et la perfusion cardiaque après un infarctus du myocarde, non seulement en mobilisant les cellules souches de la MO, mais également, en exerçant des effets cardioprotecteurs directs. Toutefois, des études complémentaires sont requises afin de clarifier lintérêt dun traitement complémentaire par du G-CSF chez les patients souffrant dinfarctus aigu du myocarde. Lobjectif du travail est dévaluer plus précisément la capacité du G-CSF à mobiliser les CSH, les CSM et les CPE et dexaminer la contribution de ces cellules aux phénomènes de réparation tissulaire cardiaque après infarctus du myocarde. Evaluation de la taille de linfarctus chez la souris par µSpect Les modèles murins sont fréquemment utilisés pour étudier les mécanismes physiopathologiques cardiaques et tester les nouvelles stratégies thérapeutiques ; toutefois, lévaluation de la fonction cardiaque reste plus difficile daccès que chez les gros animaux. Cest la raison pour laquelle nous avons mis au point un modèle dinfarctus du myocarde (IM) par occlusion de lartère coronaire chez la souris, mais également les techniques nécessaires à lexploration de la perfusion et de la fonction cardiaque. Afin de suivre lévolution des paramètres hémodynamiques cardiaques fins dans notre modèle dIM, nous avons adapté les techniques déchocardiographie et de sonde à conductance pour leur usage chez la souris. Nous avons ensuite démontré que la technique du µSpect est réalisable chez la souris et permet une détermination précise de la taille de linfarctus. En effet, vu les très petites dimensions du cur de souris, nous avions besoin dune résolution spatiale élevée que nous offre le nouveau système de Spect (Linoview Spect) : celui-ci peut en effet différencier deux points éloignés de 0,35mm. Nous obtenons effectivement des images de qualité équivalente à celles obtenues dans les études cliniques humaines. Nous avons validé cette technique en démontrant une excellente corrélation entre la taille de la zone ischémiée mesurée par µSpect et celle obtenue par les techniques histologiques de coloration au TTC ou trichrome. Nous avons également observé un faible taux de variation des valeurs inter-observation ou inter-observateur. Mobilisation des cellules progénitrices par du G-CSF chez des animaux sains Avant dévaluer la contribution du G-CSF aux phénomènes de réparation du tissu cardiaque lésé suite à une diminution de la perfusion, nous avons tout dabord étudié la capacité du G-CSF à mobiliser les cellules progénitrices hématopoïétiques (CPH), mésenchymateuses (CPM) et endothéliales (CPE). Nous voulions également vérifier limpact dun traitement par du G-CSF sur la perfusion ainsi que sur les performances du muscle cardiaque normal. Nous avons démontré que l'administration de G-CSF chez les souris induit la mobilisation en périphérie de CPH, CPM et CPE, selon une cinétique spécifique à chaque type de cellules progénitrices. Cest après trois jours de traitement par du G-CSF que nous observons un nombre maximum des trois types de progéniteurs dans la SP ; ce serait donc le jour le plus approprié pour collecter par aphérèse une population enrichie en CPH, CPM et CPE. Toutefois, ce jour de collecte est à adapter spécifiquement à chaque type de cellules progénitrices. Lanalyse échocardiographique et les mesures de pression-volume ont démontré que l'administration de G-CSF a un impact sur la fonction hémodynamique cardiaque. Ces données hémodynamiques ont révélé une relaxation anormale du cur, une compliance plus faible du ventricule gauche (VG) et une plus faible déformation du myocarde. Ces résultats pourraient suggérer que le G-CSF exerce un effet rigidifiant sur les parois ventriculaires. De plus, limagerie µSpect montre que la perfusion myocardique chez des souris saines est augmentée de façon importante, peu de temps après l'administration de G-CSF. Mobilisation des cellules progénitrices après la survenue dun IM Nous avons examiné si la survenue dun IM pouvait affecter le nombre de progéniteurs dans la moelle osseuse et le sang périphérique. Nous avons observé que le nombre de CPH et de CFU-GM diminue aussi bien dans la moelle quen circulation, probablement en conséquence de l'inhibition post-inflammatoire de l'hématopoïèse. Les nombres de CPM et la CPE de la moelle ne varient pas, tandis que les CFU-F formées à partir des cellules médullaires diminuent. Ces trois paramètres augmentent considérablement dans le SP, indiquant une mobilisation importante de ces cellules progénitrices, en réponse à l'inflammation myocardique. Il apparaît clairement que les cellules progénitrices sont spécifiquement mobilisées suite à lIM et non pas chez les « sham-operated animals », alors que ces derniers subissent lentièreté de la chirurgie, à lexception de la ligature de lartère coronaire. Mobilisation des cellules progénitrices par du G-CSF chez des animaux souffrant dIM Nous avons étudié la contribution du G-CSF à la réparation du tissu cardiaque dans notre modèle murin de ligature de lartère coronaire. Limpact sur la survie, la fonction hémodynamique cardiaque et la perfusion, de 2 timings de traitement par du G-CSF a été étudiée par lusage complémentaire de léchographie, lévaluation hémodynamique à partir de boucle pression-volume et limagerie µSpect. Pour ce faire, les animaux ligaturés sont traités par du G-CSF, soit pendant 5 jours après linfarctus, soit pendant 5J avant et 5J après la chirurgie. Une semaine après linduction de lIM, les modifications fonctionnelles et structurelles induites par linfarctus et le traitement au G-CSF sont évaluées. Les résultats que nous avons obtenus montrent que les CPM et les CPE sont davantage mobilisées dans le sang périphérique chez les souris souffrant dIM et traitées par du G-CSF que chez les animaux non traités. De plus, ladministration du G-CSF est nécessaire à la mobilisation des CPH après un IM aigu. Ladministration de G-CSF améliore la survie des animaux. En effet, la mortalité évolue de 30% chez les animaux non traités à 18% chez les animaux traités par du G-CSF dans les 5J qui suivent la ligature, et 0% de survie si les animaux sont traités 5J avant la ligature et 5J après. Le remodelage du VG est également amélioré par le G-CSF, comme le montre la diminution du poids du coeur et de la taille du VG. Nous avons alors évalué l'impact de l'administration de G-CSF sur le déficit de la perfusion et avons observé que ce paramètre, ainsi que la taille de linfarctus, sont sensiblement diminués après 10 jours de G-CSF. Nous obtenons également une évolution favorable de la perfusion entre les jours 1 et 7 chez les animaux recevant du G-CSF. Le nombre d'artérioles CD31 positives dans le coeur est également augmenté après un traitement par du G-CSF. Afin dévaluer plus précisément l'impact du traitement par du G-CSF sur la physiopathologie cardiaque chez des souris souffrant dIM, une évaluation hémodynamique de fonction cardiaque a été réalisée. Nous pouvons observer une amélioration de certains paramètres de la fonction cardiaque mais non de tous. En effet, 7 jours après la survenue de lIM, le débit cardiaque est presque totalement corrigé mais la fraction déjection du VG reste inchangée. Les paramètres de déformation du VG ne sont pas normalisés une semaine après linfarctus. Dun point de vue hémodynamique, la constante de relaxation augmente au-delà des valeurs normales après ladministration de G-CSF. De même, en fin de diastole, la pression augmente fortement, alors que le volume reste inchangé. Ces données indiquent à nouveau une altération de la relaxation du muscle cardiaque et une diminution de la compliance du VG chez les animaux traités par du G-CSF. Ces résultats confirment le potentiel du G-CSF à mobiliser les cellules progénitrices dans le sang périphérique et leur possible contribution aux phénomènes de réparation cardiaque. Le développement dun traitement par du G-CSF dans les pathologies ischémiques cardiaques est un thérapeutique non invasive qui suscite un vif intérêt, mais qui nécessite des évaluations approfondies au travers détudes fondamentales et cliniques en double aveugle et randomisées. Il faut maintenant déterminer les mécanismes par lesquels le G-CSF exer
29

Γονιδιακή μεταφορά με μη ιϊκά επισωματικά / Gene transfer into hematopoietic progenitor cells with non-viral episomal vectors

Παπαπέτρου, Ειρήνη 25 June 2007 (has links)
Τα επισωματικά αυτο-αναπαραγώμενα συστήματα αποτελούν υποσχόμενα εναλλακτικά οχήματα γονιδιακής μεταφοράς για εφαρμογές της γονιδιακής θεραπείας. Η πρόσφατη κατανόηση της ικανότητας των αλληλουχιών S/MAR να διαμεσολαβούν την επισωματική διατήρηση γενετικών στοιχείων επέτρεψε την ανάπτυξη ενός πρότυπου κυκλικού επισωματικού φορέα που λειτουργεί χωρίς να κωδικοποιεί πρωτεΐνες ιϊκής προέλευσης. Σε αυτή τη μελέτη, διερευνήθηκε για πρώτη φορά η δυνατότητα αυτού του φορέα, pEPI-eGFP, να μεσολαβεί γονιδιακή μεταφορά σε κυτταρικές σειρές προγονικών αιμοποιητικών κυττάρων καθώς και σε πρωτογενή ανθρώπινα κύτταρα και, κυρίως, σε ανθρώπινα προγονικά αιμοποιητικά κύτταρα. Δείχνουμε ότι ο φορέας pEPI-eGFP διατηρείται επισωματικά και υποστηρίζει παρατεταμένη έκφραση του γονιδίου αναφοράς eGFP, ακόμα και χωρίς πίεση επιλογής, στην ανθρώπινη κυτταρική σειρά K562, καθώς και σε πρωτογενείς ανθρώπινους ινοβλάστες. Αντίθετα, στην κυτταρική σειρά ερυθρολευχαιμίας ποντικού MEL, η έκφραση της eGFP αποσιωπάται μέσω αποακετυλίωσης ιστονών, παρά την επισωματική διατήρηση του φορέα. Προγονικά αιμοποιητικά κύτταρα με κλωνογόνο ικανότητα, προερχόμενα από αίμα ομφάλιου λώρου, διαμολύνονται αποτελεσματικά με το φορέα μέσω ηλεκτροδιάτρησης. Ημιστερεές αποικίες προερχόμενες από διαμολυσμένα CD34+ κύτταρα διατηρούν το φορέα και εκφράζουν eGFP. Μετά από 4 εβδομάδες ο φορέας διατηρείται επισωματικά σε περίπου 1% των θυγατρικών κυττάρων. Τα αποτελέσματά μας αποδεικνύουν για πρώτη φορά ότι ένα πλασμίδιο βασιζόμενο σε μια αλληλουχία S/MAR μπορεί να λειτουργεί ως σταθερό επιίσωμα σε πρωτογενή ανθρώπινα κύτταρα και, ιδιαίτερα, σε προγονικά αιμοποιητικά κύτταρα, υποστηρίζοντας παρατεταμένη έκφραση του διαγονιδίου. Η μελέτη αυτή αναδεικνύει τη χρησιμότητα του συστήματος αυτού για τους σκοπούς της γονιδιακής θεραπείας. Παράλληλα, καταδεικνύει τους στόχους στους οποίους πρέπει να επικεντρωθεί η μελλοντική έρευνα προς την κατεύθυνση της βελτίωσής του. / Episomally maintained self-replicating systems present attractive alternative vehicles for gene therapy applications. Recent insights into the ability of chromosomal scaffold/matrix attachment regions (S/MARs) to mediate episomal maintenance of genetic elements cloned in cis allowed the development of a small circular episomal vector that functions independently of virally encoded proteins. In this study, we investigated the potential of this vector, pEPI-eGFP, to mediate gene transfer in hematopoietic progenitor cell lines as well as in primary human cells and, importantly, in human hematopoietic progenitor cells. pEPI-eGFP was episomally maintained and conferred sustained eGFP expression even in nonselective conditions in the human cell line, K562, as well as in primary human fibroblast-like cells. In contrast, in the murine erythroleukemia cell line, MEL, transgene expression was silenced through histone deacetylation, despite the vector’s episomal persistence. Hematopoietic semisolid cell colonies derived from transfected human cord blood retained the vector and expressed eGFP. After 4 weeks, the vector was maintained in approximately 1% of progeny cells. Our results provide the first evidence that a S/MAR-based plasmid can function as a stable episome in primary human cells, supporting long-term transgene expression. The present study constitutes a proof of principle for the utility of this system in gene therapy applications and points at targets for future improvements.
30

Expansão ex vivo das células-tronco hematopoiéticas do sangue do cordão umbilical: análise comparativa da proliferação celular em cocultura de células-troco mesenquimais provenientes do endotélio vascular do cordão umbilical e do tecido adiposo / Cord blood hematopoietic stem cells ex vivo expansion: comparative analysis of cell proliferation promoted by adipose tissue and umbilical cord endothelium mesenchymal stem cells in coculture system

Andresa Forte 10 December 2014 (has links)
INTRODUÇÃO: As células-tronco hematopoiéticas (CTH) do sangue do cordão umbilical (SCU) têm sido utilizadas com sucesso para o tratamento de doenças malignas e não malignas. No entanto, algumas unidades de SCU podem apresentar baixa quantidade de células nucleadas totais (CNT). Algumas abordagens têm sido sugeridas para evitar problemas em relação à baixa concentração de CTH no transplante, como a administração de duas unidades de SCU para o paciente e a expansão ex vivo de CTH. OBJETIVO: Avaliar as taxas de proliferação celular na expansão ex vivo do SCU em sistema de cocultura com células-tronco mesenquimais (CTM) obtidos a partir de diferentes fontes com alta e baixa confluência e adicionando-se ou não coquetel de citocinas no meio de cultura. MÉTODOS: Este estudo foi aprovado pelo Comitê de Ética de Pesquisa (CAPPesq) do Hospital das Clínicas da Faculdade de Medicina da USP. A coleta do SCU (n =10) foi realizada após o nascimento do bebê e expulsão da placenta. O processamento foi realizado utilizando o método de redução de volume, o qual consiste em depleção de eritrócitos. As amostras de CTM provenientes do endotélio vascular do cordão umbilical foram obtidas de doadores diferentes (n=3) e o tecido adiposo (n=3) do inventário do LIM-31. A expansão das CNT e das células com expressão de marcadores CD133+/CD34+ foram observados depois de sete dias de cultura. Além disso, o ensaio para análise de unidades de formadoras de colônias (UFC) foi realizado em todas as amostras antes e depois da expansão do SCU. Para a expansão em sistema de cocultura foi separado dois grupos para ambas as fontes de CTM (Grupo I - cocultura com adição de coquetel de citocinas vs. Grupo II - cocultura sem citocinas). RESULTADOS: Após sete dias, no grupo I com cocultura confluente, a taxa de proliferação de CNT foi duas vezes maior ao comparar com cocultura subconfluente (35 vs. 16 vezes). No mesmo grupo também foi possível evidenciar elevada taxa de proliferação de células CD133+/CD34+. O índice de proliferação das UFC no grupo I aumentou até oito vezes. A cocultura subconfluente tanto do endotélio vascular do cordão umbilical como do tecido adiposo apresentou menor rendimento em comparação as CTM confluentes. A expansão das células na presença de citocinas apresentou maior proliferação celular ao comparar às coculturas sem adição de citocinas. CONCLUSÃO: Este estudo mostrou que para alto rendimento de células do SCU, o sistema de cocultura requer adição de coquetel de citocinas e CTM confluente independentemente da fonte utilizada / INTRODUCTION: Umbilical cord blood (UCB) hematopoietic stem cells have been successfully used for the treatment of both malignant and non-malignant diseases. Nevertheless, some UCB units could have low total nucleated cells (TNC) dose. Several approaches have been suggested to avoid inadequacy problems of hematopoietic stem cells (HSC) number for transplantation, such as administration of two UCB units to the patient and HSC ex vivo expansion. OBJECTIVE: Evaluate UCB ex vivo expansion proliferative rates in a high and low mesenchymal stem cells (MSC) confluence feeder layer obtained from different MSC sources and by adding or not cytokines cocktail into the medium. METHODS: This study was approved by the Research Ethic Committee (CAPPESQ) of Hospital das Clínicas da Faculdade de Medicina da USP. The collection of UCB (n=10) was made after delivery of the infant and the expulsion of placenta. Processing was performed using volume reduction method which consists in red blood depletion. MSC samples from umbilical cord endothelium were obtained from three different donors and adipose tissue (n=3) obtained from LIM31\'s pattern inventory. The total nucleated cell (TNC), expression of hematopoietic surface markers such as CD133+/CD34+ were observed after seven days of culture. Beyond that, colony forming unit assay (CFU) was performed before and after UCB expansion. The expansion by coculture method was observed in two groups (Group I - coculture with cytokines cocktail added vs. Group II- coculture without cytokines cocktail) for both MSCs sources. RESULTS: After seven days, analysis of confluent coculture showed that TNC proliferation rate ware almost 2 times higher than in subconfluent coculture (35 vs. 16-fold) in Group I and also revealed higher proliferative rate in CD133+/CD34+ cells considering. CFU showed similar increase after seven days of culture in comparison of day 0 (up to 8-fold). Subconfluent coculture for both umbilical cord endothelium and adipose tissue showed lower yield compared with those with high MSC confluence. The expansion in the presence of cytokines showed higher cell proliferation compared to the cocultures without addition of cytokines. CONCLUSION: This study showed that coculture system may require the addition of cytokines cocktail in the media and confluent MSC regardless of source for high yield of UCB cells

Page generated in 0.1235 seconds